Skip to content

A registration study of acute focal cerebral ischemia

A registration study of acute focal cerebral ischemia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015956
Enrollment
Unknown
Registered
2018-05-02
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute focal cerebral ischemia

Interventions

AIS vs control:N/A

Sponsors

Sun Yat-sen Memorial Hospital affiliated to Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: AIS group: 1. The diagnosis of all AIS patients must meet the diagnostic criteria recognized by the 4th National Conference on Cerebral Vascular Diseases and patients must be confirmed new cerebral infarction; 2. All patients must be Acute onset with neurologic deficit symptoms and theirs signs lasting more than 24 hours. The diagnosis of all AIS patients must meet the diagnostic criteria recognized by the 4th National Conference on Cerebral Vascular Diseases and patients must be confirmed new cerebral infarction; 3. The period from onset to admission must be within 72 hours; 4. All patients and their families must sign informed consent. Control group: 1. Aged 60-80 years old; 2. Without history of cerebral infarction, cerebral hemorrhage, TIA and myocardial infarction 3.Conscious with autonomous ability to act.

Exclusion criteria

Exclusion criteria: 1. Asymptomatic cerebral infarction; 2. TIA; 3. Those who got sequelaes in previous stroke; 4. Patients with other diseases including malignant tumors, cerebral hemorrhage, history of surgery or trauma in the past 2 months, severe cardiopulmonary hepatorenal disease, systemic infection at the beginning of the study, autoimmune disease with or without Immunosuppressive therapy; 5. The time from onset to treatment exceeds 72 hours; 6. Patients with seizures; 7. Patients with disturbance of consciousness, serious sensory disturbances (blindness and deafness), severe aphasia, etc; 8. Patients suffered from cognitive impairment and other neuropsychiatric disorders before the onset of AIS; 9. Final diagnosis of non-cerebral infarction by magnetic resonance or clinical symptoms; 10. Patients who failed to complete cranial magnetic resonance after 3 months.

Design outcomes

Primary

MeasureTime frame
Differential expression of metabolic substances in AIS group and control group;

Secondary

MeasureTime frame
Relationship between patient's prognosis and metabolites;

Countries

China

Contacts

Public ContactPan Suyue

Nanfang Hospital of Southern Medical University

pansuyue82@126.com+86 13556184981

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026